| Title : Metformin dose increase versus added linagliptin in non-alcoholic fatty liver disease and type 2 diabetes: An analysis of the J-LINK study - Komorizono_2021_Diabetes.Obes.Metab_23_832 |
| Author(s) : Komorizono Y , Hosoyamada K , Imamura N , Kajiya S , Hashiguchi Y , Ueyama N , Shinmaki H , Koriyama N , Tsukasa M , Kamada T |
| Ref : Diabetes Obes Metab , 23 :832 , 2021 |
| Abstract : Komorizono_2021_Diabetes.Obes.Metab_23_832 |
| ESTHER : Komorizono_2021_Diabetes.Obes.Metab_23_832 |
| PubMedSearch : Komorizono_2021_Diabetes.Obes.Metab_23_832 |
| PubMedID: 33236464 |
Komorizono Y, Hosoyamada K, Imamura N, Kajiya S, Hashiguchi Y, Ueyama N, Shinmaki H, Koriyama N, Tsukasa M, Kamada T (2021)
Metformin dose increase versus added linagliptin in non-alcoholic fatty liver disease and type 2 diabetes: An analysis of the J-LINK study
Diabetes Obes Metab
23 :832
Komorizono Y, Hosoyamada K, Imamura N, Kajiya S, Hashiguchi Y, Ueyama N, Shinmaki H, Koriyama N, Tsukasa M, Kamada T (2021)
Diabetes Obes Metab
23 :832